Standout Papers

Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers 2010 2026 2015 2020 834
  1. Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers (2010)
    Ping Chi, C. David Allis et al. Nature reviews. Cancer
  2. Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer (2022)
    Andrea López, Denis E. Reyna et al. Nature Communications
  3. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial (2020)
    Jean‐Yves Blay, César Serrano et al. The Lancet Oncology

Citation Impact

19 by Nobel laureates 14 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy
2024 Standout
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
2023 Standout
1 intermediate paper

Works of Ping Chi being referenced

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
2022 Standout
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
2013
and 1 more

Author Peers

Author PRM Gastroenterology Oncology Molecular Biology Last Decade Papers Cites
Ping Chi 1685 860 1062 2765 144 5.7k
Nuannuan Jing 5 10 420
Yumin Zhu 7 2 54 27 331
Kenth‐Arne Hansson 1 2 210 11 301
Danielle Snyderman 17 19 2 5 291
Chris DiBona 1 9 3 315

All Works

Loading papers...

Rankless by CCL
2026